Ding by HearBat · Hearing wellness

Not ready for hearing aids? Good.

Ding gives your AirPods a personalized hearing profile in 8 minutes. No beeping. No hand-raising. No appointment.

Test your hearing free
Works with AirPods Pro · iPhone required
IMAGE A — HERO 67yo woman, AirPods Pro, dinner table warm editorial photo · 4:5 fal.ai / flux-pro

Hearing loss is the #1 modifiable risk factor for dementia.

The 2024 Lancet Commission on dementia prevention identified hearing loss as the single largest modifiable risk factor, ahead of physical inactivity, depression, and smoking.

The ACHIEVE trial at Johns Hopkins found treatment can cut cognitive decline by nearly half in high-risk adults — over three years.

Lancet Commission 2024 · ACHIEVE 2023
dementia risk with mild hearing loss
dementia risk with moderate hearing loss
dementia risk with severe hearing loss
48%
reduction in cognitive decline with hearing treatment (ACHIEVE)
1.5B
people with unaddressed hearing loss worldwide
$5,000
average out-of-pocket cost of prescription hearing aids
8 min
to get your personalized Ding profile

Your hearing test was invented in 1947. Your iPhone wasn't.

The old way

Audiologist booth.

  • 3-hour appointment
  • Soundproof booth
  • Beeps, not words
  • Hand-raising
  • $200–400 out of pocket
  • Abstract threshold chart
IMAGE B — OLD TEST 1960s audiometry booth, B&W vintage · clinical · cold
The Ding way

Your couch.

  • 8 minutes
  • Your living room
  • Real words, real sentences
  • Repeat what you hear
  • Free to start
  • AirPods calibrated to you
IMAGE A.2 — DING same woman, iPhone in hand, AirPods in relaxed, warm interior · 16:9

How Ding works.

Six clinical methods, validated in peer-reviewed audiology research, compressed into a single 8-minute test. Then your AirPods do the rest.

Speech-based testing

You repeat real words and sentences out loud. Ding listens, scores you in real time, and maps where your comprehension drops off — not just your tone thresholds.

Speech-in-noise

The test runs the same speech against calibrated background noise. This is the test that predicts real-world hearing difficulty better than any tone audiogram.

Minimal pairs

Forced-choice discrimination across the consonants that fail first — b/p, f/th, s/sh. Catches the early high-frequency loss tone tests miss.

Real-time adaptation

Ding senses the environment you're in — kitchen, café, sidewalk, theater — and adjusts your AirPods' speech amplification automatically.

Your hearing profile

A personalized frequency curve, written to your AirPods in one tap. The same calibration audiologists do — without the audiologist appointment.

Dementia risk tracking

Retest monthly. Ding tracks the slope — and flags meaningful change in your speech-in-noise score, the strongest cognitive correlate in the literature.

IMAGE C — BEFORE 72yo man at dinner party desaturated body, vibrant scene around him "present but withdrawn"
Untreated
IMAGE D — AFTER same man, fully saturated leaning in, AirPods Pro visible "back in the room"
With Ding

Untreated hearing loss withdraws you from the room. Treating it brings you back.

Three ways to start.

The free version takes the test. Ding+ keeps it accurate as your hearing changes. Pro is for clinicians.

Free

Take the test
$0
Always
  • Full 8-minute hearing test
  • One-time AirPods profile
  • Basic audiogram and results
  • Speech-in-noise score
Start free

Ding Pro

For audiologists
$49 + hardware
Clinician account · invoiced
  • Everything in Ding+
  • Physical calibration coupler
  • Clinical-grade accuracy
  • Multi-patient dashboard
  • CPT-aligned export
Request access

Your AirPods can do more than you think.

8 minutes. Free. No appointment.

Test your hearing free
Ding.
Ding is a hearing wellness tool, not a medical device. It does not diagnose hearing loss or dementia. Consult a licensed audiologist or physician for clinical evaluation. Dementia-risk figures are drawn from Lin et al. 2011 and the Lancet Commission on dementia prevention (2020, 2024 update). The 48% figure is from the ACHIEVE trial (Lin et al., Lancet 2023) for high-risk adults.